BDSX

Biodesix, Inc.

1.45 USD
0.00 (0.00%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Biodesix, Inc. stock is up 18.85% since 30 days ago. The next earnings date is Aug 5, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 25% of the previous 3 May’s closed higher than April. 100% of analysts rate it a buy.

About Biodesix, Inc.

Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules.

  • TD Cowen
    Mon May 13, 07:25
    buy
    initial
  • Lake Street
    Fri May 3, 12:06
    buy
    initial